Coeptis Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Coeptis Therapeutics, Inc. reported Increase (Decrease) in Accounts Receivable of $8.07 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2022-11-08
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2021-12-31 was -$26.30K.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2021-09-30 was $4.52K, a 54.32% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2021 was -$21.79K, a 246.15% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2020 was $14.91K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $8.07K 10-Q · filed 2022-11-08 | |||
| 2021-12-31 | -$26.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$21.79K derived: sum of 2 quarters · filed 2022-11-08 | -$21.79K derived: sum of 3 quarters · filed 2022-11-08 | -$21.79K 10-K · filed 2022-03-11 |
| 2021-09-30 | $4.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.52K derived: sum of 2 quarters · filed 2022-11-08 | $4.52K 10-Q · filed 2022-11-08 | $4.52K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $9.89K derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $9.89K derived: sum of 3 quarters · filed 2022-03-11 | $12.56K derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $9.89K derived: sum of 2 quarters · filed 2022-03-11 | $12.56K derived: sum of 3 quarters · filed 2022-03-11 | $14.91K 10-K · filed 2022-03-11 |
| 2020-09-30 | $9.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $12.56K derived: sum of 2 quarters · filed 2021-11-15 | $14.91K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $2.67K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $5.02K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $2.35K 10-Q/A · filed 2021-05-18 |